These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 17130689)
1. Plasma selenium over time and cognitive decline in the elderly. Akbaraly TN; Hininger-Favier I; Carrière I; Arnaud J; Gourlet V; Roussel AM; Berr C Epidemiology; 2007 Jan; 18(1):52-8. PubMed ID: 17130689 [TBL] [Abstract][Full Text] [Related]
2. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Knopman DS; Mosley TH; Catellier DJ; Coker LH; Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884 [TBL] [Abstract][Full Text] [Related]
3. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377 [TBL] [Abstract][Full Text] [Related]
4. Measuring cognitive function with age: the influence of selection by health and survival. Euser SM; Schram MT; Hofman A; Westendorp RG; Breteler MM Epidemiology; 2008 May; 19(3):440-7. PubMed ID: 18414086 [TBL] [Abstract][Full Text] [Related]
5. Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study. Dufouil C; Fuhrer R; Alpérovitch A J Am Geriatr Soc; 2005 Apr; 53(4):616-21. PubMed ID: 15817007 [TBL] [Abstract][Full Text] [Related]
6. Selenium and cognitive impairment: a brief-review based on results from the EVA study. Berr C; Arnaud J; Akbaraly TN Biofactors; 2012; 38(2):139-44. PubMed ID: 22419540 [TBL] [Abstract][Full Text] [Related]
7. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Hanlon JT; Landerman LR; Artz MB; Gray SL; Fillenbaum GG; Schmader KE Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):781-7. PubMed ID: 15386717 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Rafnsson SB; Deary IJ; Smith FB; Whiteman MC; Fowkes FG Psychosom Med; 2007 Jun; 69(5):425-34. PubMed ID: 17556639 [TBL] [Abstract][Full Text] [Related]
9. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging. Karlamangla AS; Singer BH; Greendale GA; Seeman TE Psychoneuroendocrinology; 2005 Jun; 30(5):453-60. PubMed ID: 15721057 [TBL] [Abstract][Full Text] [Related]
10. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. Soumaré A; Tavernier B; Alpérovitch A; Tzourio C; Elbaz A J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1058-65. PubMed ID: 19561146 [TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms as a predictor of cognitive decline: MacArthur Studies of Successful Aging. Chodosh J; Kado DM; Seeman TE; Karlamangla AS Am J Geriatr Psychiatry; 2007 May; 15(5):406-15. PubMed ID: 17353297 [TBL] [Abstract][Full Text] [Related]
12. Cardio-ankle vascular index as a predictor of cognitive impairment in community-dwelling elderly people: four-year follow-up. Yamamoto N; Yamanaka G; Ishikawa M; Takasugi E; Murakami S; Yamanaka T; Ishine M; Matsubayashi K; Hanafusa T; Otsuka K Dement Geriatr Cogn Disord; 2009; 28(2):153-8. PubMed ID: 19696483 [TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Ritchie K; Carrière I; de Mendonca A; Portet F; Dartigues JF; Rouaud O; Barberger-Gateau P; Ancelin ML Neurology; 2007 Aug; 69(6):536-45. PubMed ID: 17679672 [TBL] [Abstract][Full Text] [Related]
14. Serum calcium and cognitive function in old age. Schram MT; Trompet S; Kamper AM; de Craen AJ; Hofman A; Euser SM; Breteler MM; Westendorp RG J Am Geriatr Soc; 2007 Nov; 55(11):1786-92. PubMed ID: 17979900 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of plasma folate, vitamin B12, and cognitive function and decline. Kang JH; Irizarry MC; Grodstein F Epidemiology; 2006 Nov; 17(6):650-7. PubMed ID: 17028506 [TBL] [Abstract][Full Text] [Related]
16. Physical activity and 5-year cognitive decline in the Doetinchem cohort study. Angevaren M; Vanhees L; Nooyens AC; Wendel-Vos CG; Verschuren WM Ann Epidemiol; 2010 Jun; 20(6):473-9. PubMed ID: 20470975 [TBL] [Abstract][Full Text] [Related]
17. IANA task force on nutrition and cognitive decline with aging. Gillette Guyonnet S; Abellan Van Kan G; Andrieu S; Barberger Gateau P; Berr C; Bonnefoy M; Dartigues JF; de Groot L; Ferry M; Galan P; Hercberg S; Jeandel C; Morris MC; Nourhashemi F; Payette H; Poulain JP; Portet F; Roussel AM; Ritz P; Rolland Y; Vellas B J Nutr Health Aging; 2007; 11(2):132-52. PubMed ID: 17435956 [TBL] [Abstract][Full Text] [Related]
18. Education, atrophy, and cognitive change in an epidemiological sample in early old age. Christensen H; Batterham PJ; Mackinnon AJ; Anstey KJ; Wen W; Sachdev PS Am J Geriatr Psychiatry; 2009 Mar; 17(3):218-26. PubMed ID: 19454848 [TBL] [Abstract][Full Text] [Related]
19. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Young SE; Mainous AG; Carnemolla M Diabetes Care; 2006 Dec; 29(12):2688-93. PubMed ID: 17130206 [TBL] [Abstract][Full Text] [Related]
20. Association between apolipoprotein E4 and cognitive decline in elderly adults. Packard CJ; Westendorp RG; Stott DJ; Caslake MJ; Murray HM; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Jolles J; Perry IJ; Sweeney BJ; Twomey C; J Am Geriatr Soc; 2007 Nov; 55(11):1777-85. PubMed ID: 17979899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]